Daehan Nupharm Revenue

In the year 2025, Daehan Nupharm had annual revenue of 202.40B KRW with 0.11% growth. Daehan Nupharm had revenue of 51.79B in the quarter ending December 31, 2025, with 1.59% growth.

Revenue

202.40B

Revenue Growth

+0.11%

P/S Ratio

0.49

Revenue / Employee

887.73M

Employees

228

Market Cap

99.79B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	202.40B	214.78M	0.11%
Dec 31, 2024	202.19B	-2.04B	-1.00%
Dec 31, 2023	204.22B	6.27B	3.16%
Dec 31, 2022	197.96B	31.37B	18.83%
Dec 31, 2021	166.59B	17.29B	11.58%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sam-A Pharm.	77.80B
Cosmax Nbt	287.48B
H.PIO	258.19B
Ahn-Gook Pharmaceutical	306.87B
Polaris AI Pharma	63.94B
Samik Pharmaceutical Company LTD.	60.02B
Sinsin Pharmaceutical	113.78B
GL Pharm Tech	35.27B

Revenue Rankings